PTC Therapeutics (PTCT) Misses Q2 EPS by 17c, Revenues Beat
Tweet Send to a Friend
PTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($0.75), $0.17 worse than the analyst estimate of ($0.58). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
